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Abstract
Introduction: The adverse consequences of a non-dialysis-requiring acute kidney injury (AKI) are unclear. This
study aimed to assess the long-term prognoses for critically ill patients experiencing a non-dialysis-requiring AKI.
Methods: This retrospective observational cohort study investigated non-dialysis-requiring AKI survivors in surgical
intensive care units between January 2002 and June 2010. All longitudinal post-discharge serum creatinine
measurements and information regarding end-stage renal disease (ESRD) and death were collected. We assessed
the long-term outcomes of chronic kidney disease (CKD), ESRD and all-cause mortality beyond discharge.
Results: Of the 922 identified critically ill patients with a non-dialysis-requiring AKI, 634 (68.8%) patients who survived to
discharge were enrolled. A total of 207 patients died after a median follow-up of 700.5 days. The median intervals
between the onset of the AKI and the composite endpoints “stage 3 CKD or death”, “stage 4 CKD or death”, “stage
5 CKD or death”, and “ESRD or death” were 685, 1319, 1743, and 2048 days, respectively. This finding shows a steady
long-term decline in kidney function after discharge. Using the multivariate Cox proportional hazard model, we found
that every 1 mL/min/1.73 m2 decrease from baseline estimated glomerular filtration rate (eGFR) of individuals who
progressed to stage 3, 4, and 5 CKD increased the risks of long-term mortality by 0.7%, 2.3%, and 4.1%, respectively (all
p < 0.05). This result indicates that the mortality risk increased significantly in a graded manner as kidney function
declined from the baseline eGFR to advanced stages of CKD during the follow-up period.
Conclusions: In critically ill patients who survive a non-dialysis-requiring AKI, there is a need for continuous
monitoring and kidney function protection beyond discharge.
Introduction
Acute kidney injury (AKI) is a major contributor to mor-
bidity and mortality in hospitalized patients [1]. Epidemio-
logical studies have found that there is a gradual increase
in the incidence of AKI no matter whether or not the
patient requires dialysis [2-4]. Although many studies on
patients with AKI who require dialysis have been
performed, the literature is rather limited regarding AKI
patients who do not require dialysis. Recent reports have
indicated that even the smallest changes in serum creati-
nine (SCr) pose a significant risk for adverse outcomes in
AKI patients [5,6]. AKI that does not require dialysis may
be of equal or greater importance from a public health
perspective than severe AKI requiring dialysis [7]. In addi-
tion to disease severity, some AKI patients do not receive
dialysis due to physician or patient preferences [3]. Thus,
further clinical research is warranted focusing on AKI
patients who do not receive dialysis.
The short-term adverse consequences of AKI during
acute hospital admission have been well defined [1].
Whereas the long-term risks of end-stage renal disease
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(ESRD) following AKI have also been determined [8-10],
the impact of AKI on the trajectory of decline in kidney
function remained poorly defined until only a few years
ago. Recent reports have demonstrated that a consider-
able number of patients with AKI present with only par-
tial renal recovery, suggesting that an AKI is a risk factor
for chronic kidney disease (CKD) after discharge [11-15].
However, this issue has yet to be clarified in critically ill
survivors. Furthermore, there remains a lack of direct evi-
dence on how the initiation and progression of CKD after
an AKI harm the longevity of patients. In fact, this pro-
blem is overlooked by both doctors and patients. One
report from the United States demonstrated that only a
small proportion of AKI survivors, especially those not
requiring dialysis, visited a nephrologist within 6 months
of hospital discharge [16].
We hypothesized that AKI patients not requiring dialy-
sis also have a high risk for long-term adverse outcomes.
To test this hypothesis, this study aimed to investigate
the long-term outcomes, specifically those concerning
the development or progression of CKD and mortality,
among critically ill AKI survivors following hospital dis-
charge. Special attention was also focused on the impact
of CKD progression on long-term mortality, which to the
best of our knowledge has never been reported.
Materials and methods
Study cohort
This study was a retrospective observational cohort study
based on the National Taiwan University Hospital Study
Group on Acute Renal Failure (NSARF) database estab-
lished in the surgical intensive care units (ICU) of a med-
ical center and its three branch hospitals in different
cities [17-23]. This database contains data prospectively
collected from patients with AKI during their stay in ICU
and continuously recorded data for outcome analysis.
The AKI was defined and classified according to the risk,
injury, failure, loss, and end-stage kidney (RIFLE) criteria
[24]. In the present study, we enrolled all patients who
experienced AKI and survived to discharge but did not
receive renal replacement therapy throughout the index
hospitalization between January 1 2002 and June 30
2010. Patients were excluded if they had a history of
ESRD or kidney transplantation. The follow-up period
was continued until December 31 2010.
The study was approved by the Institutional Review Board
of National Taiwan University Hospital (No.31MD03).
An informed consent was waived because there was no
breach of privacy, and the study did not interfere with the
clinical decisions related to patient care.
Clinical assessment of study patients
Baseline demographic and clinical data were assessed at
the time of hospital admission, as previously reported
[19]. Pertinent medical history included diabetes mellitus
(DM, defined as being treated with oral hypoglycemic
agents or insulin), hypertension (defined as taking anti-
hypertensive drugs or systolic and diastolic blood pres-
sure > 145/95 mmHg at the time of hospitalization), cor-
onary arterial disease (CAD, defined by the diagnosis of
ischemic heart disease prior to admission, and positive
electrocardiographic findings), cerebral vascular accidents
(CVA, ischemic or hemorrhagic), severe congestive heart
failure (CHF, defined as a New York Heart Association
(NYHA) functional class of III or IV), severe chronic
obstructive pulmonary disease (COPD, defined as requir-
ing long-term bronchodilators or steroids), metastatic
carcinoma, and hematological malignancies. Body mass
index (BMI) was calculated upon admission to the
hospital.
All of the clinical parameters and biochemical data were
recorded at ICU admission and at the peak of the AKI,
including the acute physiology and chronic health evalua-
tion (APACHE) II [25] and sequential organ failure assess-
ment (SOFA) [26] scores. Data were also recorded on the
use of inotropic drugs, expressed as inotropic equivalent
(mcg/kg/min) = dopamine + dobutamine + 100 × epi-
nephrine + 100 × norepinephrine + 100 × isoprotenolol +
15 × milrinone [27]; mechanical ventilation; cardiopul-
monary resuscitation (CPR); intra-aortic balloon pump
(IABP); extracorporeal membrane oxygenation (ECMO);
total parenteral nutrition (TPN), and any history of sur-
gery (elective or emergent). Body weight change was cal-
culated as the percentage change from ICU admission to
the peak of the AKI.
Baseline SCr was determined as the last value measured
at least one month, but no more than a year, prior to the
index admission [28]. For patients without valid premorbid
data, we used the lowest SCr value during the index
admission [29]. The estimated glomerular filtration rate
(eGFR) was calculated via the Modification of Diet in
Renal Disease (MDRD) equation [30]. By using both SCr
and urine output criteria, the maximum RIFLE stage
throughout the index hospitalization was determined [24].
All of the longitudinal SCr measurements after the index
hospitalization and during the follow-up period were col-
lected for each enrolled patient. For every post-discharge
SCr measurement, the eGFR was calculated via the
MDRD equation [30]. All of the eGFR data were derived
from SCr measurements, with the exception of the eGFR
at 90 days after the onset of the AKI (post-90d-eGFR).
It was suggested that AKI patients should be evaluated for
the new onset or worsening of pre-existing CKD at least 3
months after the onset of AKI [31-33]. Thus, we estimated
the SCr at 90 days after the onset of AKI via linear inter-
polation from the two closest SCr measurements before
and after the 90-day period from the onset of AKI. The
post-90d-eGFR was then calculated from the estimated
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SCr at 90 days after the onset of AKI. In patients who did
not have a SCr measurement at > 90 days after the onset
of an AKI, the post-90d-eGFR was characterized as
unknown.
Outcomes
The endpoints included stages 3 to 5 CKD entries, ESRD,
and mortality during the follow-up period. Stage 3 to
5 CKD entries were defined as the first day when the
eGFR decreased below 60, 30, and 15 mL/min/1.73 m2,
respectively. ESRD was the certification by a nephrologist
of the need for long-term dialysis, as determined from the
national Taiwan Renal Registry Data System, which
receives data on all dialysis patients every 3 months.
Patient survival after discharge was determined from the
National Health Insurance Research Database (NHIRD)
[34] in February 2011. The NHIRD contains health care
data on > 99% of the entire population in Taiwan and cov-
ers all inpatient and outpatient medical benefit claims.
The survival period was calculated from the onset of AKI
until each outcome, whichever came first.
Statistical analyses
Statistical analyses were performed using Stata 10.0 (Sta-
taCorp, College Station, TX, USA) and R 2.11.1 (R Foun-
dation for Statistical Computing, Vienna, Austria). A
two-sided P value ≤ 0.05 was considered statistically sig-
nificant. The distributional properties of the continuous
variables were presented by either means ± SD or med-
ians (25th, 75th percentiles), whereas categorical vari-
ables were presented as frequencies and percentages. The
differences between the groups were assessed using the
chi square (c2) test, Fisher’s exact test, and the two-
sample t-test, as indicated.
The impact of AKI on the prognoses of the initial CKD
or non-CKD patients was carefully evaluated stepwise.
First, allowing 3 months as a reasonable period of the
time for patients to recover from the AKI [31-33], we
considered 90 days after the onset of AKI as the starting
point to examine the endpoints of CKD entries, using a
Cox proportional hazards model. Specifically, stages 3, 4,
and 5 CKD were assessed only in patients with post-90d-
eGFR ≥ 60, 30, and 15 mL/min/1.73 m2, respectively.
Therefore, the patients eligible for the assessment of
stage 3 CKD were also eligible for the risk assessments of
stage 4 and 5 CKD, and the patients eligible for the risk
assessment of stage 4 CKD were also eligible for the risk
assessment of stage 5 CKD. In addition, all of the
enrolled patients were eligible for the risk assessments of
ESRD and long-term mortality after the onset of AKI.
The Kaplan-Meier method was applied to estimate survi-
val curves for all the outcomes.
Next, to examine the harmful effects of a CKD entry
and ESRD on a patient’s time to death, the time-
dependent variables of stage 3, 4, and 5 CKD (CKD3, 4,
5-TD), ESRD (ESRD-TD), and the related interaction
terms were put into the Cox regression analysis model.
Technically, the original wide-form data (n = 634) were
reconstructed into a long-form structure (n = 53,833)
using the so-called counting process style of input for the
specified Cox regression model [35,36]. Then at each
ordered event time, we recorded the values of the CKD3-
TD, CKD4-TD, CKD5-TD, ESRD-TD, and the related
interaction terms for each of the patients at risk in the
transformed long-form data set.
The basic model-fitting techniques for (1) stepwise
variable selection, (2) goodness-of-fit assessment, and (3)
regression diagnostics (for example, the verification of
proportional hazards assumption, residual analysis, detec-
tion of influential cases, and determination of multicolli-
nearity) were used in our regression analyses.
Results
Of the 922 patients identified with AKI that did not
require dialysis, 634 patients (68.8%) who survived to
discharge were enrolled. The ages of the included
patients ranged from 16 to 92 years (mean 64.4 ± 15.7
years), and there were 218 women (34.4%) and 182 dia-
betic patients (28.7%). Thirty-two patients had a history
of organ transplantation (excluding renal transplanta-
tion); of this group, sixteen patients were liver recipi-
ents, fifteen were heart recipients, and one was a lung
recipient. With respect to the baseline renal function,
399 patients (62.9%) had a preserved eGFR. The propor-
tions of patients in each maximum RIFLE stage were as
follows: 34.9% (n = 221) were in the risk stage, 36.0%
(n = 228) were in the injury stage, and 29.2% (n = 185)
were in the failure stage. The demographic and clinical
characteristics of the study population are presented in
Table 1.
The development and progression of CKD during the
long-term follow-up period
According to the calculated post-90d-eGFR, renal func-
tion status at 90 days after the onset of AKI is shown in
Table 2A. At that time, only 187 patients (29.5%) had a
preserved eGFR, while 244 (38.5%) had CKD. A post-
90d-eGFR could not be obtained in the 160 patients
(25.2%) who had no SCr measurement at > 90 days
after the onset of AKI and in the 43 patients (6.8%) who
died before 90 days after the onset of AKI.
The long-term outcomes pertaining to stage 3, 4, and
5 CKD were only assessed in hospital survivors who had
a post-90d-eGFR ≥ 60 (n = 187), 30 (n = 374), and
15 mL/min/1.73 m2 (n = 421), respectively (Table 2B).
All 634 patients were assessed for the long-term risks of
ESRD and mortality (Table 2B). The median time inter-
val between the onset of the AKI and the development
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of stage 3 and 4 CKD was 740 and 1,984 days, respec-
tively. Only 35 patients (5.5%) developed stage 5 CKD,
and 13 patients (2.1%) developed ESRD during the fol-
low-up period (Figure 1A).
All-cause mortality and composite outcomes during
follow-up
The median follow-up duration was 700.5 (330.5, 1,296)
days. The endpoint of all-cause mortality occurred in
207 patients (32.7%). The Kaplan-Meier curves showed
that the median patient survival time was 2,178 days
after the onset of AKI (Figure 1B).
The development of advanced CKD and mortality are
competitive endpoints, as many AKI survivors do not live
long enough to develop advanced CKD. We therefore
assessed the composite outcomes. The median survival
time of patients assessed for the composite endpoints
“stage 3 CKD or death”, “stage 4 CKD or death”, “stage 5
CKD or death”, and “ESRD or death”, were 685, 1,319,
1,743, and 2,048 days following the onset of AKI, respec-
tively (Table 3 and Figure 1C).
Risk factors for long-term outcomes
A Cox proportional hazards model, adjusted for all of the
variables listed in Table 1 including baseline eGFR, was
conducted to identify the independent factors associated
with each composite outcome (Table 4). It was found
that age was consistently a risk factor for all of the com-
posite endpoints. A higher baseline eGFR was protective
against the composite outcomes of “stage 3 CKD or
death” and “stage 4 CKD or death”. When assessing the
composite outcomes of “stage 4 CKD or death” and
“stage 5 CKD or death”, SCr at the peak of the AKI
appeared to be an important risk factor.
Additionally, another Cox proportional hazards model,
adjusted for all of the variables listed in Table 1, including
baseline eGFR, was performed to evaluate the independent
factors associated with long-term mortality. Time-
Table 1 The demographic and clinical characteristics of
the included patients (n = 634)
Demographic data
Age, years 64.4 ± 15.7
Women 218 (34.4)
BMI (kg/m2) 24.1 ± 4.4
Baseline eGFR (mL/kg/min) 75.7 ± 40.1
Baseline renal function
preserved eGFR 399 (62.9)
stage 3 CKD 190 (30.0)
stage 4 CKD 38 (6.0)






Severe CHF* 130 (20.5)
Severe COPD† 19 (3.0)
Organ transplantation 32 (5.1)
Metastatic carcinoma 23 (3.6)
Hematological malignancies 3 (0.5)
ICU admission
Admission year
2002 – 2005 168 (26.5)
2006 - 2010 466 (73.5)








chest surgery 29 (4.6)
cardiovascular surgery 330 (52.1)
neurosurgery 36 (5.7)
general surgery 239 (37.7)
Surgery during admission 576 (90.9)
Emergency surgery 186 (29.3)





MAP (mmHg) 89.3 ± 15.7
Body weight change (%) -0.2 ± 4.5
Hemoglobin (g/dL) 10.9 ± 2.0
Lactate (mmol/L) 2.5 ± 2.5
Creatinine (mg/dL) 2.5 ± 1.3
Urine output (mL/d) 2,057.1 ± 1,220.7
Albumin (g/dL) 3.3 ± 0.7
CVP level (mmHg) 10.3 ± 4.0
Inotropic equivalent (mcg/kg/min)§ 5.5 ± 14.1
Table 1 The demographic and clinical characteristics of
the included patients (n = 634) (Continued)
APACHE II score 9.1 ± 5.3
SOFA score 7.2 ± 3.4
Data are presented as the mean ± standard deviation or the number and
corresponding percentage (%).*Defined as New York Heart Association functional
class III or IV. † Defined as requiring treatment with long-term bronchodilators or
steroids. † Defined and classified according to the highest RIFLE stage throughout
the hospitalization. §Inotropic equivalent (mcg/kg/min) = dopamine +
dobutamine + 100 × epinephrine + 100 × norepinephrine + 100 ×
isoprotenolol + 15 × milrinone. AKI, acute kidney injury; APACHE II, acute
physiology and chronic health evaluation II score; BMI, body mass index; CAD,
coronary arterial disease; CHF, congestive heart failure; CKD, chronic kidney
disease; COPD, chronic obstructive pulmonary disease; CPR, cardiopulmonary
resuscitation; CVA, cerebral vascular accident; CVP, central venous pressure;
ECMO, extracorporeal membrane oxygenation; eGFR, estimated glomerular
filtration rate; IABP, intra-aortic balloon pump; MAP, mean arterial pressure; SOFA,
sequential organ failure assessment score; TPN, total parenteral nutrition.
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dependent CKD3, 4, 5-TD, ESRD-TD, and the related
interaction terms were also included in the regression
model. After adjusting for the effects of the other covari-
ates in the final model, the interaction terms of baseline
eGFR and CKD3, 4, and 5-TD, but not ESRD-TD, signifi-
cantly predicted long-term mortality (Table 5). The main
CKD3, 4, and 5-TD factors themselves were not significant
in the final model. The hazard ratios (HRs) product sug-
gested a 0.7%, 2.3% (1.007*1.016 = 1.023), and 4.1%
(1.023*1.017 = 1.041) increase in mortality risk for every 1
mL/min/1.73 m2 decrease from baseline eGFR in indivi-
duals who progressed to stage 3, 4, and 5 CKD during the
long-term follow-up period, respectively. In other words,
among patients with the same baseline kidney function,
those who progressed to more advanced CKD had a
higher risk of death. Furthermore, among the patients who
progressed to the same stage of CKD during the follow-up
period, those who had a higher baseline eGFR had a
higher risk of death. This indicated that mortality risk
increased significantly in a graded manner with kidney
function decline from baseline eGFR to the advanced
stages of CKD during the follow-up period. The other risk
factors for long-term mortality included age (HR 1.04),
receiving general surgical services (HR 1.77), and the
administration of CPR during ICU admission (HR 6.55).
Conversely, patients who received organ transplantation
(HR 0.29) and who had a higher mean arterial pressure at
the peak of the AKI (HR 0.98) appeared to be at less of a
risk for mortality during the follow-up period. The interac-
tion term of CPR and ECMO indicating a higher grade of
life support during resuscitation, also predicted a lower
risk of death after discharge (HR 0.17). This final model
passed the test for proportional hazards assumption and
fit the data well (adjusted R2 = 0.289).
Discussion
Studies of AKI that does not require dialysis are relatively
scant, despite the increasing prevalence of patients with
this condition [2,3]. This may be attributed to the
difficulty of identifying such cases with diagnosis codes
[3,37]. In the present study, we identified AKI patients
based on their changes in SCr and followed their every
available SCr measurement after their hospital discharge.
This enabled us to study the long-term outcomes of
CKD and mortality in critically ill patients with AKI that
did not require dialysis.
In the past, it was generally accepted that AKI survivors
had good renal outcomes, as assessed by a low incidence
of ESRD [38,39]. However, this assumption was recently
challenged [15]. In one study, it was found that 72.1% of
older patients without pre-existing renal failure devel-
oped CKD within 2 years of AKI [8]. Two separate large
cohort studies both demonstrated that AKI is an inde-
pendent predictor of the development of advanced CKD
[11,12]. Ishani et al. also reported that the magnitude of
the increase in SCr after cardiac surgery was associated
with an increasing long-term risk of incident CKD, pro-
gression of CKD, and mortality [14]. Last, another analy-
sis in a cohort undergoing coronary angiography revealed
a quicker eGFR decline following an episode of AKI [13].
Patients admitted into the ICU have a higher rate of
early mortality than other populations investigated in
this field of research [15]. Consequently, clinicians may
pay more attention to the risk of death rather than the
progression to advanced CKD. Our findings extend the
knowledge of this issue to critically ill patients, where a
steady deterioration of kidney function was observed in
AKI survivors (Figure 1 and Table 3). A subset of
patients in our cohort demonstrated a short-term recov-
ery of kidney function and had a post-90d-eGFR ≥ 60
mL/min/1.73 m2 with a median of 75.3 (66.1, 92.5).
Approximately half of these patients (49.7%) progressed
to CKD during the long-term follow-up period (Table
3). Among these patients, the median interval prior to
developing stage 3 CKD was approximately 2 years (Fig-
ure 1A) and was even shorter for the composite end-
point of “stage 3 CKD or death” (Figure 1C). Regarding
advanced CKD, the median interval from the onset of
Table 2 The distribution of renal function status at 90 days following the onset of AKI and the assessment of long-
term outcomes
(A) Renal function status at 90 days
following the onset of AKI (n = 634)




n Assessment of long-term outcomes Eligible patients n
(I) Preserved eGFR 187 (29.5%) Stage 3 CKD post-90d-eGFR ≥ 60 mL/min/1.73 m2 187 (I)
(II) Stage 3 CKD 187 (29.5%) Stage 4 CKD post-90d-eGFR ≥ 30 mL/min/1.73 m2 374 (I+II)
(III) Stage 4 CKD 47 (7.4%) Stage 5 CKD post-90d-eGFR ≥ 15 mL/min/1.73 m2 421 (I+II+III)
(IV) Stage 5 CKD 10 (1.6%) ESRD all hospital survivors 634 (I+II+III+IV+V+VI)
(V) Unknown 160 (25.2%) Mortality all hospital survivors 634 (I+II+III+IV+V+VI)
(VI) Death before 90 days 43 (6.8%)
AKI, acute kidney injury; CKD, chronic kidney disease; post-90d-eGFR, estimated glomerular filtration rate at 90 days after AKI; preserved eGFR, estimated
glomerular filtration rate 60 mL/min/1.73 m2 or higher.
Lai et al. Critical Care 2012, 16:R123
http://ccforum.com/content/16/4/R123
Page 5 of 10
AKI was less than 4 years to reach the composite out-
come of “stage 4 CKD or death”, and less than 6 years
to reach “ESRD or death” (Figure 1C). These data
indicate that we should not view AKI only as a self-lim-
iting acute disease but also as a long-lasting progressive
disorder.
Figure 1 The Kaplan-Meier survival curve for time (days) from AKI onset to long-term outcomes. (A) Time to stage 3 to 5 CKD or ESRD;
(B) time to all-cause mortality; (C) time to composite outcomes of “stage 3 CKD or death”, “stage 4 CKD or death”, “stage 5 CKD or death”, and
“ESRD or death”. AKI: acute kidney injury; CKD: chronic kidney disease; ESRD: end-stage renal disease.
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The predictive value of the interaction term of base-
line eGFR and CKD entry for long-term mortality is a
novel finding. In the present study, we collected detailed
patient demographic and clinical data during episodes of
AKI, including the APACHE II and SOFA scores. This
enabled us to adjust the patients’ characteristics, base-
line renal function, and severity of acute illness to evalu-
ate the effect of CKD progression on long-term
mortality. We demonstrated that with a higher baseline
kidney function and more advanced CKD progression,
there is a greater risk of death (Table 5). This observa-
tion suggests that a gradual decline in long-term renal
function in non-dialysis-requiring AKI survivors not
only reflects kidney dysfunction, but also survival. Thus,
one potential modifiable factor for improving the long-
term survival of AKI hospital survivors is to prevent the
deterioration of their renal function.
Interestingly, the identified risk factors presented in
Table 4 are not the same across each long-term
composite outcome. This may be due to the different
eligibilities of patients accessed for different endpoints.
Given that this was a retrospective observational study,
we cannot confirm the causal relationship of these vari-
ables with progressive renal failure. Besides, organ trans-
plant is found to be an independent protective factor for
stage 5 CKD and mortality (Table 4 and 5). These recipi-
ents were selected for transplantation before surgery and
followed up more carefully after discharge. In contrast,
patients receiving general surgical services were more
likely to have stage 5 CKD or to have died during the
long-term follow-up period (Table 4 and 5). Most non-
general surgical patients in our cohort received cardio-
vascular surgical services. The majority of kidney damage
in cardiovascular surgical patients resulted from cardio-
pulmonary bypass-related ischemia-reperfusion injury.
This type of AKI may have a better prognosis than septic
AKI [40]. Furthermore, there were 33.9% of AKI patients
receiving general surgical services reached the maximum
Table 3 The observations for composite endpoints















Stage 3 CKD or death 187 306 (178.5, 763.5) 93 (49.7) 10 (5.3) 103 (56.3) 685
Stage 4 CKD or death 374 509.5 (258.2, 957) 92 (24.6) 50 (13.4) 142 (38.0) 1319
Stage 5 CKD or death 421 631 (298, 1074) 35 (8.3) 91 (21.6) 126 (29.9) 1743
ESRD or death 634 692.5 (309.8, 1285) 13 (2.1) 202 (31.9) 215 (33.9) 2,048
*Observation period is presented as the median (25th, 75th percentile); † event is presented as the number and corresponding percentage (%)
CKD: chronic kidney disease; ESRD: end-stage renal disease.
Table 4 A multivariate Cox proportional hazards model for independent factors associated with the composite
outcomes
Composite outcome Covariate HR (95% CI) P
Stage 3 CKD or death baseline eGFR 0.99 (0.98, 1.00) 0.02
(n = 187) age 1.02 (1.00, 1.03) 0.02
Stage 4 CKD or death received surgery 0.42 (0.25, 0.72) 0.002
(n = 374) hypertension 0.56 (0.39, 0.80) 0.002
baseline eGFR 0.99 (0.98, 1.00) 0.009
age 1.04 (1.02, 1.06) < 0.001
SCr at the peak of AKI 1.20 (1.04, 1.38) 0.01
diabetes 1.79 (1.25, 2.58) 0.002
IABP 1.88 (1.14, 3.09) 0.01
Stage 5 CKD or death organ transplantation 0.30 (0.09, 0.96) 0.04
(n = 421) BMI 0.94 (0.90, 0.99) 0.02
age 1.04 (1.03, 1.06) < 0.001
SCr at the peak of AKI 1.20 (1.05, 1.36) 0.006
general surgical services 2.09 (1.45, 3.01) < 0.001
CPR 3.22 (1.36, 7.62) 0.008
AKI, acute kidney injury; BMI, body mass index; CI, confidence interval; CPR, cardiopulmonary resuscitation; eGFR, estimated glomerular filtration rate; HR, hazard
ratio; IABP, intra-aortic balloon pump; SCr, serum creatinine.
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RIFLE stage of failure, in comparison to the 26.3% of
other AKI patients (P = 0.04).
Our study had limitations. First, 25.2% of the hospital
survivors did not have any SCr measurements beyond
the 90-day period after AKI onset, and 6.8% of the hos-
pital survivors died before that interval. Those patients
without long-term follow-up of kidney function were
more likely to be women and to have a history of CVA,
and less likely to receive organ transplantation and to
use TPN (Additional file 1). Despite this, the linking of
this study with the national registry database on ESRD
and death provides accurate information regarding these
two endpoints. Second, only critically ill patients with
AKI not requiring dialysis were studied; as a result, we
are unable to generalize our findings to more severe
AKI requiring dialysis or to other populations. Compari-
sons among patients with AKI, who did or did not
require dialysis, and CKD without superimposed AKI,
also could not be made in this study. Furthermore, the
relative risk for CKD or the long-term mortality brought
on by AKI could not be determined in this study due to
a lack of appropriate non-AKI controls. Despite these
limitations, other studies in the literature that provide
this information also have similar findings [10-15].
Third, the status of the baseline proteinuria, presence of
sepsis, and etiology of AKI were not identified. Recently,
these variables were identified as important factors
affecting short- and long-term prognosis after AKI
[21,40,41]. In this study, we included all available demo-
graphic data and clinical information for analysis, but
residual confounding might still exist to some extent
due to unmeasured and unknown risk factors. Last, this
retrospective observational study cannot prove that AKI
plays a causal role in CKD progression or that aggres-
sive follow-up after discharge would improve these
long-term outcomes, as there was no pre-specified
protocol for post-discharge care and SCr follow-up.
Prospective studies with structured, multidisciplinary,
follow-up medical care for AKI survivors are warranted
to clarify this issue [42].
Conclusions
The present study demonstrated the gradual decline in
kidney function after hospital discharge in critically ill
patients with AKI, who did not require dialysis. Further-
more, there appeared to be an association between the
deterioration of kidney function and long-term mortality.
This finding underscores the need to explore the
mechanisms that are responsible for the long-term con-
sequences of an AKI. Additionally, there is a need for
novel strategies that focus on retarding renal function
deterioration and strengthening the continuous surveil-
lance of kidney function in AKI survivors.
Key messages
• Long-term trajectories of kidney function after AKI
in critically ill survivors are not well-defined, especially
in those who have not received dialysis. This issue is
possibly overlooked in post-discharge medical care.
• A considerable portion of critically ill patients, who
survived AKI that did not require dialysis, had CKD
during long-term follow-up.
• We revealed that there was a steady long-term
decline in kidney function after hospital discharge.
Therefore, we should not view AKI only as a self-
limiting acute disease, but also as a long-lasting pro-
gressive disorder.
• The mortality risk increased significantly in a
graded manner with the decline in kidney function
from baseline eGFR to advanced stages of CKD dur-
ing the follow-up period.
• We need to organize multidisciplinary medical care
for critically ill AKI survivors to continually monitor
kidney function after discharge. One potential modifi-
able factor to improve long-term survival of patients
with AKI after discharge from hospital is to prevent
the deterioration of their kidney function.
Additional material
Additional file 1: A table showing the demographic and clinical
characteristics of survivors stratified by follow-up duration.
Table 5 A multivariate Cox proportional hazards model
with time-dependent variables for the independent
factors of long-term mortality (N = 53,833)
Covariate HR (95% CI) P
Demographic data
organ transplantation 0.29 (0.09, 0.98) 0.05
age 1.04 (1.02, 1.05) < 0.001
ICU admission and surgery
CPR*ECMO* 0.17 (0.03, 0.99) 0.048
MAP at the peak of AKI 0.99 (0.97, 1.00) 0.006
general surgical services 1.77 (1.19, 2.64) 0.005
receive CPR 6.55 (2.34, 18.32) < 0.001
Time-dependent variables during follow-up*†
preserved eGFR during follow-up 1 reference
baseline eGFR*CKD3-TD 1.007 (1.001, 1.012) 0.016
baseline eGFR*CKD4-TD 1.016 (1.010, 1.021) < 0.001
baseline eGFR*CKD5-TD 1.017 (1.008, 1.026) < 0.001
baseline eGFR*ESRD-TD 1.054 (0.959, 1.158) 0.3
AKI, acute kidney injury; CI, confidence interval; CKD, chronic kidney disease;
CPR, cardiopulmonary resuscitation; ECMO, extracorporeal membrane
oxygenation; eGFR, estimated glomerular filtration rate; ESRD, end-stage renal
disease; HR, hazard ratio; MAP, mean arterial pressure. *CPR*ECMO indicates
the interaction term of receiving both CPR and ECMO; Baseline eGFR*CKD3 (4,
5)-TD indicates the interaction term of baseline eGFR and stage 3 (4, 5) CKD
time-dependent variables; Baseline eGFR*ESRD-TD indicates the interaction
term of baseline eGFR and ESRD. † The main CKD3, 4, 5-TD factors were not
significant in the final model.
Lai et al. Critical Care 2012, 16:R123
http://ccforum.com/content/16/4/R123
Page 8 of 10
Abbreviations
AKI: acute kidney injury; APACHE: acute physiology and chronic health
evaluation; BMI: body mass index; CAD: coronary arterial disease; CHF:
congestive heart failure; CKD: chronic kidney disease; COPD: chronic
obstructive pulmonary disease; CPR: cardiopulmonary resuscitation; CVA:
cerebral vascular accident; DM: diabetes mellitus; ECMO: extracorporeal
membrane oxygenation; eGFR: estimated glomerular filtration rate: ESRD:
end-stage renal disease; HR: hazard ratio; IABP: intra-aortic balloon pump;
ICU: intensive care unit; MDRD: Modification of Diet in Renal Disease; NHIRD:
National Health Insurance Research Database; NYHA: New York Heart
Association; post-90d-eGFR, estimated glomerular filtration rate at 90 days
after AKI; RIFLE: risk, injury, failure, loss, and end-stage kidney; SCr: serum
creatinine; SOFA: sequential organ failure assessment; TPN: total parenteral
nutrition.
Acknowledgements
This study was supported by the Ta-Tung Kidney Foundation, Mrs Hsiu-Chin
Lee Kidney Research Fund, Taiwan National Science Council (grant NSC 96-
2314-B-002-033-MY2, NSC 97-2314-B-002-155-MY2), and National Taiwan
University Hospital (NTUH 098-001177, NTUH 100-001667). The authors
would like to thank the all participants of the NSARF.
Author details
1Department of Internal Medicine, National Taiwan University Hospital and
National Taiwan University College of Medicine, 7 Chung Shan S Rd, Taipei
100, Taiwan. 2Department of Internal Medicine, National Taiwan University
Hospital Yun-Lin Branch, 579 Sec 2, Yunlin Rd, Douliou City, Yunlin County
640, Taiwan. 3Department of Anesthesiology, National Taiwan University
Hospital and National Taiwan University College of Medicine, 7 Chung Shan
S Rd, Taipei 100, Taiwan. 4Department of Surgery, National Taiwan University
Hospital and National Taiwan University College of Medicine, 7 Chung Shan
S Rd, Taipei 100, Taiwan. 5Department of Traumatology, National Taiwan
University Hospital and National Taiwan University College of Medicine, 7
Chung Shan S Rd., Taipei 100, Taiwan. 6Department of Internal Medicine,
Saint Mary’s Hospital, 160 Chung-Chen S Rd., Luodong, Yilan County 265,
Taiwan. 7International Harvard Statistical Consulting Company, 7F-11, 57
Chongqing S Rd, Taipei 100, Taiwan.
Authors’ contributions
CFL conceived the study, participated in data collection, performed statistical
analysis, interpreted results, and wrote the manuscript. VCW, TMH, YFL, YJJ,
CTC, and CCS participated in data collection and manuscript revision. YCY,
KCW, YYH, PRT, and NKC participated in data collection. FCH performed
statistical analysis, participated in data interpretation and manuscript writing.
WJK and KDW conceived the study and participated in manuscript revision.
All authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 2 April 2012 Revised: 4 June 2012 Accepted: 12 July 2012
Published: 12 July 2012
References
1. Ricci Z, Cruz D, Ronco C: The RIFLE criteria and mortality in acute kidney
injury: A systematic review. Kidney Int 2008, 73:538-546.
2. Xue JL, Daniels F, Star RA, Kimmel PL, Eggers PW, Molitoris BA,
Himmelfarb J, Collins AJ: Incidence and mortality of acute renal failure in
Medicare beneficiaries, 1992 to 2001. J Am Soc Nephrol 2006,
17:1135-1142.
3. Hsu CY, McCulloch CE, Fan D, Ordonez JD, Chertow GM, Go AS:
Community-based incidence of acute renal failure. Kidney Int 2007,
72:208-212.
4. Hsu CY: Where is the epidemic in kidney disease? J Am Soc Nephrol 2010,
21:1607-1611.
5. Lassnigg A, Schmidlin D, Mouhieddine M, Bachmann LM, Druml W, Bauer P,
Hiesmayr M: Minimal changes of serum creatinine predict prognosis in
patients after cardiothoracic surgery: a prospective cohort study. J Am
Soc Nephrol 2004, 15:1597-1605.
6. Lafrance JP, Miller DR: Acute kidney injury associates with increased long-
term mortality. J Am Soc Nephrol 2010, 21:345-352.
7. Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW: Acute kidney
injury, mortality, length of stay, and costs in hospitalized patients. J Am
Soc Nephrol 2005, 16:3365-3370.
8. Ishani A, Xue JL, Himmelfarb J, Eggers PW, Kimmel PL, Molitoris BA,
Collins AJ: Acute kidney injury increases risk of ESRD among elderly. J
Am Soc Nephrol 2009, 20:223-228.
9. Wald R, Quinn RR, Luo J, Li P, Scales DC, Mamdani MM, Ray JG: Chronic
dialysis and death among survivors of acute kidney injury requiring
dialysis. JAMA 2009, 302:1179-1185.
10. James MT, Ghali WA, Knudtson ML, Ravani P, Tonelli M, Faris P, Pannu N,
Manns BJ, Klarenbach SW, Hemmelgarn BR: Associations between acute
kidney injury and cardiovascular and renal outcomes after coronary
angiography. Circulation 2011, 123:409-416.
11. Amdur RL, Chawla LS, Amodeo S, Kimmel PL, Palant CE: Outcomes
following diagnosis of acute renal failure in U.S. veterans: focus on
acute tubular necrosis. Kidney Int 2009, 76:1089-1097.
12. Lo LJ, Go AS, Chertow GM, McCulloch CE, Fan D, Ordonez JD, Hsu CY:
Dialysis-requiring acute renal failure increases the risk of progressive
chronic kidney disease. Kidney Int 2009, 76:893-899.
13. James MT, Ghali WA, Tonelli M, Faris P, Knudtson ML, Pannu N,
Klarenbach SW, Manns BJ, Hemmelgarn BR: Acute kidney injury following
coronary angiography is associated with a long-term decline in kidney
function. Kidney Int 2010, 78:803-809.
14. Ishani A, Nelson D, Clothier B, Schult T, Nugent S, Greer N, Slinin Y,
Ensrud KE: The magnitude of acute serum creatinine increase after
cardiac surgery and the risk of chronic kidney disease, progression of
kidney disease, and death. Arch Intern Med 2011, 171:226-233.
15. Coca SG, Singanamala S, Parikh CR: Chronic kidney disease after acute
kidney injury: a systematic review and meta-analysis. Kidney Int 2012,
81:442-448.
16. National Institutes of Heath, National Institute of Diabetes and Digestive
and Kidney Diseases: US Renal Data System: USRDS 2010 Annual Data
Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the
United State Bethesda, MD; 2010.
17. Tsai CW, Lin YF, Wu VC, Chu TS, Chen YM, Hu FC, Wu KD, Ko WJ: SAPS 3 at
dialysis commencement is predictive of hospital mortality in patients
supported by extracorporeal membrane oxygenation and acute dialysis.
Eur J Cardiothorac Surg 2008, 34:1158-1164.
18. Lin YF, Ko WJ, Wu VC, Chen YS, Chen YM, Hu FC, Shiao CC, Wu MS,
Chen YW, Li WY, Huang TM, Wu KD, Chu TS: A modified sequential organ
failure assessment score to predict hospital mortality of postoperative
acute renal failure patients requiring renal replacement therapy. Blood
Purif 2008, 26:547-554.
19. Shiao CC, Wu VC, Li WY, Lin YF, Hu FC, Young GH, Kuo CC, Kao TW,
Huang DM, Chen YM, Tsai PR, Lin SL, Chou NK, Lin TH, Yeh YC, Wang CH,
Chou A, Ko WJ, Wu KD: Late initiation of renal replacement therapy is
associated with worse outcomes in acute kidney injury after major
abdominal surgery. Crit Care 2009, 13:R171.
20. Wu VC, Wang CH, Wang WJ, Lin YF, Hu FC, Chen YW, Chen YS, Wu MS,
Lin YH, Kuo CC, Huang TM, Chen YM, Tsai PR, Ko WJ, Wu KD: Sustained
low-efficiency dialysis versus continuous veno-venous hemofiltration for
postsurgical acute renal failure. Am J Surg 2010, 199:466-476.
21. Huang TM, Wu VC, Young GH, Lin YF, Shiao CC, Wu PC, Li WY, Yu HY,
Hu FC, Lin JW, Chen YS, Lin YH, Wang SS, Hsu RB, Chang FC, Chou NK,
Chu TS, Yeh YC, Tsai PR, Huang JW, Lin SL, Chen YM, Ko WJ, Wu KD:
Preoperative proteinuria predicts adverse renal outcomes after coronary
artery bypass grafting. J Am Soc Nephrol 2011, 22:156-163.
22. Chou YH, Huang TM, Wu VC, Wang CY, Shiao CC, Lai CF, Tsai HB, Chao CT,
Young GH, Wang WJ, Kao TW, Lin SL, Han YY, Chou A, Lin TH, Yang YW,
Chen YM, Tsai PR, Lin YF, Huang JW, Chiang WC, Chou NK, Ko WJ, Wu KD,
Tsai TJ: Impact of timing of renal replacement therapy initiation on
outcome of septic acute kidney injury. Crit Care 2011, 15:R134.
23. Wu VC, Huang TM, Lai CF, Shiao CC, Lin YF, Chu TS, Wu PC, Chao CT,
Wang JY, Kao TW, Young GH, Tsai PR, Tsai HB, Wang CL, Wu MS,
Chiang WC, Tsai IJ, Hu FC, Lin SL, Chen YM, Tsai TJ, Ko WJ, Wu KD: Acute-
on-chronic kidney injury at hospital discharge is associated with long-
term dialysis and mortality. Kidney Int 2011, 80:1222-1230.
24. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P: Acute renal failure -
definition, outcome measures, animal models, fluid therapy and
information technology needs: the Second International Consensus
Lai et al. Critical Care 2012, 16:R123
http://ccforum.com/content/16/4/R123
Page 9 of 10
Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care
2004, 8:R204-212.
25. Knaus WA, Draper EA, Wagner DP, Zimmerman JE: APACHE II: a severity of
disease classification system. Crit Care Med 1985, 13:818-829.
26. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H,
Reinhart CK, Suter PM, Thijs LG: The SOFA (Sepsis-related Organ Failure
Assessment) score to describe organ dysfunction/failure. On behalf of
the Working Group on Sepsis-Related Problems of the European Society
of Intensive Care Medicine. Intensive Care Med 1996, 22:707-710.
27. Chen YS, Lin JW, Yu HY, Ko WJ, Jerng JS, Chang WT, Chen WJ, Huang SC,
Chi NH, Wang CH, Chen LC, Tsai PR, Wang SS, Hwang JJ, Lin FY:
Cardiopulmonary resuscitation with assisted extracorporeal life-support
versus conventional cardiopulmonary resuscitation in adults with in-
hospital cardiac arrest: an observational study and propensity analysis.
Lancet 2008, 372:554-561.
28. Hsu CY, Ordonez JD, Chertow GM, Fan D, McCulloch CE, Go AS: The risk of
acute renal failure in patients with chronic kidney disease. Kidney Int
2008, 74:101-107.
29. Lafrance JP, Miller DR: Defining acute kidney injury in database studies:
the effects of varying the baseline kidney function assessment period
and considering CKD status. Am J Kidney Dis 2010, 56:651-660.
30. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate
method to estimate glomerular filtration rate from serum creatinine: a
new prediction equation. Modification of Diet in Renal Disease Study
Group. Ann Intern Med 1999, 130:461-470.
31. Macedo E, Bouchard J, Mehta RL: Renal recovery following acute kidney
injury. Curr Opin Crit Care 2008, 14:660-665.
32. Bell M: Acute kidney injury: new concepts, renal recovery. Nephron Clin
Pract 2008, 109:c224-228.
33. Improving Global Outcomes (KDIGO): Kidney Disease: KDIGO Clinical
Practice Guideline for Acute Kidney Injury. Section 2: AKI Definition.
Kidney International Supplements 2012, 2:19-36.
34. National Health Insurance Research Database, National Health Research
Institutes, R.O.C.(Taiwan). [http://nhird.nhri.org.tw].
35. Time-dependent repeated measurements of a covariate. SAS/STAT® 91
User’s Guide Cary, NC: SAS Institute Inc; 2004, 3291-3298.
36. Time-dependent repeated measurements of a covariate. SAS/STAT® 92
User’s Guide. 2 edition. Cary, NC: SAS Institute Inc; 2009, 4675-4682.
37. Vlasschaert ME, Bejaimal SA, Hackam DG, Quinn R, Cuerden MS, Oliver MJ,
Iansavichus A, Sultan N, Mills A, Garg AX: Validity of administrative
database coding for kidney disease: a systematic review. Am J Kidney Dis
2011, 57:29-43.
38. Briggs JD, Kennedy AC, Young LN, Luke RG, Gray M: Renal function after
acute tubular necrosis. Br Med J 1967, 3:513-516.
39. Liano F, Tenorio MT, Rodriguez-Mendiola N, Ponte B: Acute kidney injury
as a risk factor for chronic kidney diseases in disadvantaged
populations. Clin Nephrol 2010, 74(Suppl 1):S89-94.
40. Bagshaw SM, George C, Bellomo R: Early acute kidney injury and sepsis: a
multicentre evaluation. Crit Care 2008, 12:R47.
41. Wu VC, Huang TM, Wu PC, Wang WJ, Chao CT, Yang SY, Shiao CC, Hu FC,
Lai CF, Lin YF, Han YY, Chen YS, Hsu RB, Young GH, Wang SS, Tsai PR,
Chen YM, Chao TT, Ko WJ, Wu KD: Preoperative proteinuria is associated
with long-term progression to chronic dialysis and mortality after
coronary artery bypass grafting surgery. PLoS One 2012, 7:e27687.
42. Go AS, Parikh CR, Ikizler TA, Coca S, Siew ED, Chinchilli VM, Hsu CY,
Garg AX, Zappitelli M, Liu KD, Reeves WB, Ghahramani N, Devarajan P,
Faulkner GB, Tan TC, Kimmel PL, Eggers P, Stokes JB: The assessment, serial
evaluation, and subsequent sequelae of acute kidney injury (ASSESS-
AKI) study: design and methods. BMC Nephrol 2010, 11:22.
doi:10.1186/cc11419
Cite this article as: Lai et al.: Kidney function decline after a non-
dialysis-requiring acute kidney injury is associated with higher long-
term mortality in critically ill survivors. Critical Care 2012 16:R123.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Lai et al. Critical Care 2012, 16:R123
http://ccforum.com/content/16/4/R123
Page 10 of 10
